首页> 外文期刊>European review for medical and pharmacological sciences. >Long non-coding RNA BCAR4 accelerates cell proliferation and suppresses cell apoptosis in gastric cancer via regulating MAPK/ERK signaling
【24h】

Long non-coding RNA BCAR4 accelerates cell proliferation and suppresses cell apoptosis in gastric cancer via regulating MAPK/ERK signaling

机译:长期非编码RNA BCAR4通过调节MAPK / ERK信号传导,加速细胞增殖并抑制胃癌细胞凋亡

获取原文
           

摘要

OBJECTIVE: As the fourth most common malignant tumor with high mortality rate, gastric cancer (GC) seriously threatens people’s health and life quality worldwide. The aim of this study was to explore the functional role of long non-coding RNA (lncRNA) BCAR4 in GC. PATIENTS AND METHODS: Quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) assay was used to detect the expression level of lncRNA BCAR4 in GC cell lines and tissues. Subsequently, cell counting kit-8 (CCK-8) assay, colony formation assay, and flow cytometry were recruited to investigate the role of lncRNA BCAR4 in the proliferation and apoptosis of GC cells, respectively. Western blotting was used to detect the protein expression level of mitogen-activated protein kinase (MAPK)/extracellular-signal-regulated kinase (ERK) in GC. Besides, tumor formation assay was applied to examine the ability of lncRNA BCAR4 in vivo. RESULTS: LncRNA BCAR4 was highly expressed in both GC tissues and cell lines. CCK-8 assay, colony formation assay, and flow cytometry results indicated that up-regulated lncRNA BCAR4 significantly promoted cell proliferation and suppressed cell apoptosis in GC. Besides, over-expression of lncRNA BCAR4 could activate the MAPK/ERK signaling pathways. Tumor xenograft formation assay demonstrated that over-expression of lncRNA BCAR4 promoted tumor formation in vivo. CONCLUSIONS: LncRNA BCAR4 was proved significantly up-regulated in GC. Over-expression of lncRNA BCAR4 promoted cell proliferation and suppressed cell apoptosis in vitro and promoted tumor formation in vivo. Besides, Western blotting revealed that lncRNA BCAR4 played an oncogenic role in GC via regulating MAPK/ERK signaling.
机译:目的:作为第四个具有高死亡率的恶性肿瘤,胃癌(GC)严重威胁着全世界人民的健康和生活质量。本研究的目的是探讨长期非编码RNA(LNCRNA)BCAR4在GC中的功能作用。患者和方法:定量实时 - 聚合酶链反应(QRT-PCR)测定用于检测GC细胞系和组织中LNCRNA BCAR4的表达水平。随后,募集细胞计数试剂盒 - 8(CCK-8)测定,菌落形成测定和流式细胞术,以研究LNCRNA BCAR4分别在GC细胞增殖和凋亡中的作用。用于检测GC中丝裂剂活化蛋白激酶(MAPK)/细胞外信号调节激酶(ERK)的丝裂原蛋白激活蛋白激酶(MAPK)/细胞外信号调节激酶(ERK)的蛋白质表达水平。此外,应用肿瘤形成测定以检测LNCRNA BCAR4在体内的能力。结果:LNCRNA BCAR4在GC组织和细胞系中高度表达。 CCK-8测定,菌落形成测定和流式细胞术结果表明,上调的LNCRNA BCAR4显着促进了GC中的细胞增殖和抑制细胞凋亡。此外,LNCRNA BCAR4的过表达可以激活MAPK / ERK信号通路。肿瘤异种移植物形成测定证明,LNCRNA BCAR4的过表达促进体内肿瘤形成。结论:在GC中证明LNCRNA BCAR4显着上调。 LNCRNA BCAR4的过表达促进细胞增殖和体外抑制细胞凋亡,促进体内肿瘤形成。此外,Western印迹显示,LNCRNA BCAR4通过调节MAPK / ERK信号传导在GC中发挥了致癌作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号